These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 17032147

  • 1. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
    Kominsky SL, Doucet M, Brady K, Weber KL.
    J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM.
    Oncogene; 2009 Feb 19; 28(7):1005-15. PubMed ID: 19079339
    [Abstract] [Full Text] [Related]

  • 3. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ.
    Cancer Res; 2003 Jun 01; 63(11):2940-7. PubMed ID: 12782601
    [Abstract] [Full Text] [Related]

  • 4. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.
    Oncogene; 2002 Jan 03; 21(1):108-18. PubMed ID: 11791181
    [Abstract] [Full Text] [Related]

  • 5. Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis.
    Kominsky SL, Abdelmagid SM, Doucet M, Brady K, Weber KL.
    Cancer Res; 2008 Mar 01; 68(5):1261-6. PubMed ID: 18316587
    [Abstract] [Full Text] [Related]

  • 6. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 7. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
    Shimabukuro T, Ohmoto Y, Naito K.
    J Urol; 2003 May 28; 169(5):1865-9. PubMed ID: 12686863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.
    Clin Cancer Res; 2008 Aug 01; 14(15):4961-70. PubMed ID: 18676771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M, Oyasu R.
    Cell Growth Differ; 1997 Aug 01; 8(8):921-6. PubMed ID: 9269901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL, Pathak S, Multani AS, Price JE.
    J Urol; 2002 Aug 01; 168(2):774-9. PubMed ID: 12131367
    [Abstract] [Full Text] [Related]

  • 19. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A, Zhu Y, Cibull ML, Bao L, Chen C, Sun L.
    Cancer Res; 1999 Oct 01; 59(19):5041-6. PubMed ID: 10519421
    [Abstract] [Full Text] [Related]

  • 20. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
    Kloth JN, Fleuren GJ, Oosting J, de Menezes RX, Eilers PH, Kenter GG, Gorter A.
    Carcinogenesis; 2005 Sep 01; 26(9):1493-502. PubMed ID: 15878915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.